A growing need for cell therapy is anticipated to lead to an expansion of the global market for cell processing. For many illnesses like cancer, autoimmune disease, and neurological disease, cell therapy is the sole curative option. A million or more stem cell transplants were carried out worldwide in 2012, according to the Worldwide Network for Blood and Marrow Transplantation (WBMT). Another important element influencing the size of the cell processing industry is ongoing research and development for novel approaches for cell isolation, concentration, and preservation. Researchers have created a new magnetic ratcheting mechanism to separate and organize cells contained in fluid samples based on their tiny biochemical distinctions, according to a University of California, Los Angeles (UCLA) research paper from 2016. The system can differentiate therapeutic cells from non-therapeutic cells, perform simple, rapid automation of cell analysis, and sort cells more rapidly and precisely. Due to the rising number of cell banks in countries like China, India, Singapore, and Malaysia, the Asia Pacific cell processing market's revenue is anticipated to experience considerable increase over the forecast period.
According to Coherent Market Insights, in 2022, the market for Cell Processing was estimated to be worth USD 4.77 billion. From 2023 to 2030, it is anticipated that the market will expand at a CAGR of 16.5%.
Major Players in the Cell Processing Industry:
1. GE Healthcare
The firm was founded in 1892 and is based in Boston, Massachusetts, United States. A global leader in financial services and technology, General Electric Company. The company offers a range of goods and services, from industrial goods to medical imaging, corporate and consumer financing, water treatment, and home appliances. To increase the global availability of HA gas turbine services, GE will expand the scope of its Singapore repair centre in June 2023.
2. Becton, Dickinson and Company
The company was established in 1897 and has its headquarters in New Jersey, U.S. The business produces and markets reagents, instrument systems, and medical equipment. BD receives FDA 510(k) clearance in March 2023 for the first-ever high-throughput diagnostic test for infectious vaginitis. BD will launch a High-Throughput Single-Cell Multiomics Platform in February 2023 to broaden the scope of scientific discovery.
3. Merck KGaA
The company was started in 1668 and is based in Darmstadt, Germany. Merck makes pharmaceuticals, vaccines, biologic treatments, and items for animal health. In September 2022, the business stated it would merge with Merck Animal Health after paying an unknown price for the cattle management firm Vence. In February 2021, Merck Animal Health acquired PrognostiX Poultry.
4. Thermo Fisher Scientific
The business was started in 1956 and is based in Waltham, Massachusetts, United States. The company offers software services, consumables and reagents, and scientific equipment. In January 2021, Thermo Fisher Scientific announced that it had paid Groupe Novasep SAS €725 million in cash to acquire Henogen SA, a Belgian manufacturer of viral vectors. In October 2022, an agreement was signed between the business and the British diagnostics firm The Binding Site Group.
5. Beckman Coulter, Inc.
The company was started in 1935 and is based in Brea, California, United States. The business creates, produces, and sells goods that innovate, automate, and simplify difficult biological testing. The DxI 9000 Access Immunoassay Analyzer from Beckman Coulter, which offers the highest productivity per footprint, was revealed in May 2023.
6. Lonza Group
The company was started in 1897 and is based in Basel, Switzerland. The business offers custom biopharmaceutical manufacturing, as well as detection equipment and services for the bioscience industry, to the pharmaceutical and biologic industries. Lonza Specialty Ingredients sold itself to Bain and Cinven in July 2021 for CHF 4.2 billion.
7. Sartorius AG
The company was founded in 1870 and is based in Göttingen, Germany. An international provider of pharmaceutical and laboratory equipment, Sartorius AG specializes in the Bioprocess Solutions and Lab Products & Services markets. In 2020, the business purchased a number of Danaher Corporation's assets, including items for the study and creation of cell treatments.
*Definition: Cell processing entails a number of steps, starting with the collecting of cells from donors and continuing through cell extraction, storage, and distribution to recipients for cell therapy.
